TheChek News Flow

Didn't have an exact date on HSR refiling, but said was coming up on expiration date. Received comments back on S-4 filing (filed 12/22) waiting on DOJ before refiling. Draft filing made with EC. Other regulatory will fall in line after hearing from DOJ.

Gapping down

Gapping down In reaction to disappointing earnings/guidance: QUIK -31.7%, ADEP -25.5%, IRBT -10.4%, GMCR -9.8%, RSTI -9.2%, LFVN -7.5%, IMMU -7%, AXTI -6.5%, FBHS -6.3%, PMT -6.2%, PRU -4.9%, ATML -4.8%, (announces initial quarterly dividend of $0.04/share), FOXA -4.8%, GEOS -4.8%, KORS -4.4%, NUS -4.2%, GIL -4%, (also announces agreement to acquire Comfort Colors for $100 Million), APO -3.4%, CMI -3.3%, EL -2.8%, ALL -2.7%, (also Increases quarterly dividend ), FMC -2.3%, TDC -2.3%, AZN -2%, PRLB -1.6%, UA -1.5%, (announces the acquisition of Endomondo for $85 mln and MyFitnessPal for $475 mln), BCO -1.5%, CHTR -1.3%, ZUMZ -0.9%, (Zumiez reports Jan same store sales +12.3% vs +6.0% Retail Metrics consensus ), CNW -0.9%

Other news: BIND -5.4% (Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock; details not disclosed, ICPT -3.3% (prices 1 mln shares of its common stock at $176.00 per share), ANTM -3.3% (was victim of cyber attack, according to reports), SABR -3.2% (prices 23.8 mln shares of common stock by existing stockholders affiliated with TPG Global and Silver Lake Management and certain members of Company management at a price of $20.75 per share), MBII -2.9% (Marrone Bio Innovations announces completion of Audit Committee Investigation; update on financial statement review and status of NASDAQ Continued Listing), CASM -2.5% ( intends to offer $8.0 million worth of its common stock in an underwritten public offering), RARE -2.2% (prices 3 mln shares of its common stock at $54.00 per share), NBG -2.1% (Athens stocks down 5% in European trade), XOMA -1.8% (filed for $300 mln mixed securities shelf offering; co also also filed for offering of ~12.1 mln shares of common stock issuable upon the exercise of warrants) PBR -1.2% (confirmed that Fitch Ratings reviewed Petrobras' debt ratings from BBB to BBB-), TKMR -1% ( announces filing of Definitive Proxy Statement and voluntary delisting from the TSX following the agreement and plan of merger and reorganization with OnCore Biopharma)

Analyst comments: NAV -4% (downgraded to Underweight from Overweight at JP Morgan), COST -3% (downgraded to Hold from Buy at Deutsche Bank), RL -1.2% (downgraded to Neutral from Buy at Goldman; downgraded to Neutral from Buy at UBS), M -1% ( downgraded to Equal-Weight from Overweight at Morgan Stanley), ADP -0.7% (downgraded to Market Perform from Outperform at BMO Capital)

Gapping up In reaction to strong earnings/guidance: GLUU +20.6%, (will partner with Katy Perry on the development of a new mobile game ), DATA +16.5%, KIRK +12.7%, INUV +10.7%, EXAR +10.6%, GRA +6.4%, AFOP +6.1%, PRCP +5.6%, NICE +5.3%, LCI +4.6%, GPRE +4.5%, CONN +4.5%, MPWR +4.2%, BLL +4%, SNN +3.9%, CATM +3.4%, LB +3.3%, FORM +3%, BGC +2.4%, LAZ +2.3%, PSEC +1.8%, SNY +1.8%, CX +1.7%, SIRI +1.4%, SNY +1.4%, DNKN +1.3%, PRGO +1.3%, BOOT +1.2%, VMC +1.2%, RRTS +0.9%, WFT +0.9%, TEVA +0.9%

M&A news: HSP +35.3% (Pfizer (PFE) to acquire hospira for $90 a share), BT +5.8% (agrees definitive terms to acquire EE for GBP12.5 bln to create the UK's leading communications provider), PFE +3.1% (to acquire HSP)

Select financial related names showing strength: HERO +7.4%, CRZO +6.9%, GDP +4.8%, BBEP +4.1%, MPET +3.7%, OAS +3.3%, SDRL +2.4%, BP +1.4%, RDS.A +0.9%

Other news: SMRT +16.4% (announced a $5 per share special dividend) FXCM +9.2% (cont vol pre-mkt), FTR +8.5% (attributed to potential Verizon (VZ) deal to buy its Wireline assets), GENE +7.6% (announced yesterday that its Nasdaq deficiencies had successfully been remediated), RXDX +4.3% (receives orphan drug designation from FDA for Entrectinib for the treatment of molecularly defined subsets of non-small cell lung cancer), NGD +3.9% (reported FY14 gold production of 380,135 ounces; sees FY15 gold production of 390-430k ounces), GALE +3.7% (announces that its partner, Orexo AB, has filed a patent infringement lawsuit in United States District Court against Actavis Laboratories (ACT) and Andrx Corporation), OCN +3.6% (discloses company update, expects to record a loss in the fourth quarter of 2014 and for the total year), TWTR +3% (Bloomberg report Twitter has stuck a deal with Google to make tweets easier to search through the search engine), YNDX +2.1% (released a new app that helps drivers in Moscow find a parking space and pay for the service without leaving their car), SHAK +2.1% (cont vol pre-mkt), SE +2.1% (Spectra Energy and Spectra Energy Partners (SEP) announce 2015 business outlook and financial plan), AST +1.8% (announces public offering of common stock; price and size details not disclosed), GSK +1.7% (following peer SNY earnings), TASR +1.7% (announced the purchase of 700 AXON Flex body cameras as well as 700 five-year Unlimited and RMS Integration licenses to EVIDENCE.com by the Maricopa County Sheriff's Office ), GRPN +1.4% (plans to sell stake in Ticket Monster, according to reports)

Analyst comments: BRCD +3.6% (upgraded to Buy from Sell at Citigroup ), FITB +1% (upgraded to Buy from Neutral at BofA/Merrill )